FIELD: chemistry; pharmacology.
SUBSTANCE: compounds of formula (I) as inhibitors of phosphotyrosine phosphotase 1B and their pharmaceutically acceptable salts, their application, based pharmaceutical composition and method of production. In general formula (I) 
, R1 indicates phenyl, naphthyl, thionaphthyl, pyridyl. Phenyl, naphthyl, thionaphthyl and pyridyl can be single- or multiple-substituted with F, Cl, Br, (CH2)0-2OH, (C1-C6)-alkyl, (C2-C6)-alkenyl, (C2-C6)-alkinyl, CF3, OCF3, N(R9)(R10), piperidinone, piperazine, piperazinone, N-(C1-C6-alkylene)-piperazine, N-(C1-C6-alkylene)-piperazinone, morpholine, thiomorpholine, NO2, CN, O-(C1-C6)-alkyl, S(O)0-2-(C1-C6)-alkyl, SO2-N(R9)(R10), CO-(C1-C6)-alkyl, -COOH, (C1-C6)-alkylene-COOH, COO(C1-C6)-alkyl, (C1-C6)-alkyleny-COO(C1-C6)-alkyl, (C3-C10)-cycloalkyl, phenyl. These piperidinone, piperazine, piperazinone, N-(C1-C6-alkylene)-piperazine, N-(C1-C6-alkylene)-piperazinone, morpholine, thiomorpholine, and phenyl rings can be single- or multiple-substituted with F, Cl, Br, (CH2)0-2OH, COOH, CN, NO2, O-(C1-C6)-alkyl, -NH-O-(C1-C6)-alkyl, -(CO)-NH-O-(C1-C6)-alkylene-N(R9)(R10), -(CO)-(C1-C6)-alkyl, -(C1-C6)-alkyl, CF3, OCF3, N(R9)(R10); R2 indicates H, (C1-C6)-alkyl, COOH, (C1-C6)-alkylene-COOH, COO(C1-C6)-alkyl, (C1-C6)-alkylene-COO(C1-C6)-alkyl; R3 indicates H, (C1-C6)-alkyl, (C1-C6)-alkylenphenyl, -C(O)-phenyl, (C1-C6)-alkylenheterocycle, where heterocycle represents 5-6-merous heterocyclic ring containing 1-2 heteroatoms, chosen of nitrogen and oxygen, CO-(C1-C6)alkyl; R4, R5 indicate H; R6 indicates H, R9 indicates H, (C1-C4)-alkyl; R10 indicates H, (C1-C4)-alkyl.
EFFECT: applications for treating diseases mediated with phosphotyrosine phosphotase 1B activity, such as diabetes type II, lipidosis and carbohydrate metabolic imbalance, insulin resistivity, reduced sugar content in blood.
9 cl, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED DERIVATIVES OF OXAZOL-BENZOISOTHIAZOLDIOXIDE, METHOD FOR MAKING AND APPLYING THEREOF | 2005 |
|
RU2377242C2 |
| DERIVATIVES OF PHENYLUREA SUBSTITUTED WITH CARBOXYLIC ACID AMIDE AND THEIR USING AS MEDICINAL AGENTS | 2002 |
|
RU2291858C2 |
| METHOD OF PRODUCING OXAZOLES THROUGH CONDENSATION OF AROMATIC ALDEHYDES WITH ALPHA-KETOXIMES WITH FORMATION OF N-OXIDES AND SUBSEQUENT REACTION WITH ACTIVATED ACID DERIVATIVES | 2005 |
|
RU2402537C2 |
| DERIVATIVES OF 1,3-DIARYL-2-PYRIDINE-2-YL-3-(PYRIDINE-2-YLAMINO)PROPANOL AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1999 |
|
RU2224748C2 |
| SUBSTITUTED 8,8A-DIHYDRO-3AH-INDENO[1,2-D]THIAZOLES, METHOD FOR THEIR PREPARING AND THEIR USING AS MEDICINAL AGENTS | 2001 |
|
RU2263669C2 |
| DERIVATIVES OF 8,8A-DIHYDROINDENO[1,2-d]THIAZOLE SUBSTITUTED AT 8A POSITION, METHOD FOR THEIR PREPARING AND THEIR APPLYING AS MEDICINAL AGENTS, FOR EXAMPLE, AS ANORECTICS | 2001 |
|
RU2261860C2 |
| DERIVATIVES OF 8,8A-DIHYDROINDENO[1,2-D]THIAZOLE COMPRISING SUBSTITUTE WITH SULFONAMIDE OR SULFONE STRUCTURE AT POSITION 2, METHOD FOR THEIR PREPARING AND THEIR APPLYING AS MEDICINAL AGENT | 2001 |
|
RU2263113C2 |
| POLYCYCLIC THIAZOLIDINE-2-YLIDENE AMINES, MEDICINAL AGENTS CONTAINING THEREOF AND METHOD FOR PREPARING MEDICINAL AGENT | 1999 |
|
RU2236405C2 |
| CONJUGATES OF BINDER (ADC) WITH KSP INHIBITORS | 2014 |
|
RU2698697C2 |
| 5-SUBSTITUTED ALKYLAMINOPYRAZOLE DERIVATIVES AS PESTICIDES | 2003 |
|
RU2308452C2 |
